Ordeniza, Lexie Zane Y.
HRN: 21-35-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFUROXIME 1.5GM (VIAL)
10/17/2022
10/23/2022
IV
150mg
Q8
PCAP
Waiting Final Action
10/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2022
10/23/2022
IV
53mg
Q8
PCAP
Waiting Final Action